Efficacy of Local Treatment in Prostate Cancer Patients with Clinically Pelvic Lymph Node-positive Disease at Initial Diagnosis-Reference-Cited by-同舟云学术

Efficacy of Local Treatment in Prostate Cancer Patients with Clinically Pelvic Lymph Node-positive Disease at Initial Diagnosis

Published:2018-03 Issue:3 Volume:73 Page:452-461
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Seisen Thomas,Vetterlein Malte W.,Karabon Patrick,Jindal Tarun,Sood Akshay,Nocera Luigi^ORCID,Nguyen Paul L.,Choueiri Toni K.,Trinh Quoc-Dien,Menon Mani,Abdollah Firas^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Trends in metastatic breast and prostate cancer--lessons in cancer dynamics;Welch;N Engl J Med,2015

3. (68)Ga-PSMA positron emission tomography/computed tomography provides accurate staging of lymph node regions prior to lymph node dissection in patients with prostate cancer;Herlemann;Eur Urol,2016

4. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement;Ann Intern Med,2008

5. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement;Moyer;Ann Intern Med,2012

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Volumetric Modulated Arc Therapy for High-Risk and Very High-Risk Locoregional Prostate Cancer in the Modern Era: Real-World Experience from an Asian Cohort;Cancers;2024-08-25

2. Hypofractionated radiation therapy combined with androgen deprivation therapy for clinically node-positive prostate cancer;Radiation Oncology Journal;2024-06-30

3. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

4. A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3);Frontiers in Oncology;2024-01-11

5. Survival After Cryotherapy Versus Radiotherapy in Low and Intermediate Risk Localized Prostate Cancer;Clinical Genitourinary Cancer;2023-12